No Result
View All Result
Tuesday, November 17, 2026
MM News
اردو
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
MM News
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
No Result
View All Result
No Result
View All Result
MM News
اردو
  • Latest
  • National
  • Crime
  • Opinions
  • The Other Side-Pakistan
Home Uncategorized

Chinese drugmakers to supply more than half a billion vaccines to COVAX

MM News Staff by MM News Staff
July 13, 2021
Reading Time: 2 mins read
The new deals include Chinese drugmakers Sinopharm and Sinovac vaccines. Source: Reuters

The new deals include Chinese drugmakers Sinopharm and Sinovac vaccines. Source: Reuters

GENEVA: The Global Alliance for Vaccines and Immunization (GAVI) has signed two advance purchase agreements with Chinese drugmakers Sinopharm and Sinovac to provide up to 550 million COVID-19 vaccines to the COVAX programme.

The new deals include up to 170 million doses of the Sinopharm shot and up to 380 million shots of the Sinovac vaccine, through to the middle of 2022, the statement said.

“The agreements, which come at a time when the Delta variant is posing a rising risk to health systems, will begin to make 110 million doses immediately available to participants of the COVAX Facility, with options for additional doses,” GAVI said.

ADVERTISEMENT

GAVI, which runs the global vaccine sharing scheme COVAX with the World Health Organization (WHO) did not immediately provide details of which countries would receive the doses. Deliveries can start quickly because both vaccines have already been granted emergency use listing by the WHO, GAVI Chief Executive Officer Seth Berkley said.

COVAX, which distributes vaccines to poorer countries, has struggled to meet its early commitments amid Indian export disruptions, forcing many countries to freeze their inoculation programmes in their early phases.

However, its latest supply forecast shows that the programme is on track to deliver more than 2 billion doses by early 2022. The vaccines by Sinovac and Sinopharm join nine other vaccines and vaccine candidates already in the programme including those by AstraZeneca and Moderna.

Some countries including Thailand and Indonesia which used Sinovac as a first dose are switching to other shots for the second dose to increase protection against COVID-19.

The WHO said on June 1 when it approved Sinovac’s shot that results showed it prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalisation in 100% of the studied population. The Sinopharm vaccine has an estimated efficacy of 79% for all age groups, the WHO said in early May when it approved the shot.

Tags: ChinacoronaviruscovaxsinopharmSinovacvaccines
ShareTweetSendShare
Previous Post

Kuwait Emir accepts invitation to visit Pakistan

Next Post

Australian scientists develop pain-free blood sugar test for diabetics

Related Stories

Uncategorized

Emergency at Tarbela Hydropower Project as Water Enters Tunnel Construction Area

November 9, 2026
Photo, online
Uncategorized

Riyadh Air Suspends Flights from Riyadh Until November 7, Operations Shift to Qassim

October 25, 2026
File photo
Uncategorized

Tiger Shroff Case: Suspects Surveyed Salman & Amitabh’s Homes

October 22, 2026
File
Uncategorized

Petrol at Rs387, Diesel at Rs397 per Litre! When Will the Shehbaz Government Give Relief to the Public?

October 17, 2026
Next Post
The scientists developed a non-invasive, printable saliva test strip for diabetics. Source: Reuters

Australian scientists develop pain-free blood sugar test for diabetics

Latest

Armenia TV Studio Turns Into a Battleground! Guests Fight Live on Air, Watch Video

4 hours ago

Gold Prices Remain Stable in Pakistan as Tola Rate Holds at Rs408,936

4 hours ago

Oil Prices Fall Worldwide, US Reserves Hit Lowest Level Since 1982

5 hours ago

Saudi Riyal at Rs74, UAE Dirham at Rs76! Check Today’s Forex Rates

5 hours ago

Indian Under-19 Female Cricketer’s Alleged Suicide Raises Questions, Police Begin Probe

1 day ago

PM Shehbaz, Field Marshal Asim Munir Top World’s 500 Influential Muslims

1 day ago

From Nuclear Tests to Hidden Mineral Wealth: Chagai Makes Headlines Again

1 day ago

Dollar Nears Rs280 Mark in Pakistan? Latest Currency Rates Announced

1 day ago

Latest

Armenia TV Studio Turns Into a Battleground! Guests Fight Live on Air, Watch Video

4 hours ago

Gold Prices Remain Stable in Pakistan as Tola Rate Holds at Rs408,936

4 hours ago

Oil Prices Fall Worldwide, US Reserves Hit Lowest Level Since 1982

5 hours ago

Saudi Riyal at Rs74, UAE Dirham at Rs76! Check Today’s Forex Rates

5 hours ago

Indian Under-19 Female Cricketer’s Alleged Suicide Raises Questions, Police Begin Probe

1 day ago

PM Shehbaz, Field Marshal Asim Munir Top World’s 500 Influential Muslims

1 day ago

MM Digital (Pvt.) Ltd.

MM News is a subsidiary of the MM Group of Companies. It was established in 2019 with the aim of providing people of Pakistan access to unbiased information. Contact Details: 03200201537

Quick Links

  • Home
  • Advertise
  • MM News Urdu
  • The Other Side-Pakistan
  • Contact Us
  • Privacy Policy

Top Pages

  • Latest News
  • Showbiz
  • OP-ED
  • Technology
No Result
View All Result
  • Latest News
  • National
  • Crime
  • Opinions

© Copyright 2024 MMNews - All Rights Reserved.